WJWeiqiang Ji

Weiqiang Ji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Weiqiang Ji has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Guangming Pan

    Guangdong Provincial Hospital of Chinese Medicine; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou, Guangdong

    2 shared publications
  • Xu Zou

    The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China

    2 shared publications
  • Chaoyang Zheng

    Guangdong Provincial Hospital of Chinese Medicine; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine , Guangzhou, Guangdong

    1 shared publication
  • Haiyu Yang

    Jiangmen Wuyi Hospital of Traditional Chinese Medicine , Jiangmen, Guangdong

    1 shared publication
  • Haohong Shan

    Guangzhou Zengcheng District Hospital of Traditional Chinese Medicine , Guangzhou, Guangdong

    1 shared publication
  • Lan Wu

    Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

    1 shared publication

Latest Publications

  • Open Access

    Effects of Multifaceted Optimization Management for Chronic Heart Failure: A Multicentre, Randomized Controlled Study

    by Guangming Pan, Weiqiang Ji, Xia Wang, Song Li, Chaoyang Zheng, Weihui Lyu, Xiaoyan Feng, Yu Xia, Zhihua Xiong, Haohong Shan, et al.

    Aims: In recent years, we have developed the concept of ‘clinical pathway based on integrated traditional Chinese and western medicine for the management of Chronic heart failure (CHF)’. The purpose of this study was to assess the implementation effects of multifaceted optimization management of chronic heart failure. Methods: A total of nine physicians in optimization group from nine research sites received multifaceted intervention (a 1-day training session on how to implement the optimization programme, a written optimization programme for CHF management, supervision from daily quality coordinator, and 1-monthly monitoring and feedback of performance measure) with respect to the management of CHF, comparing to nine physicians in control group who did not receive the aforementioned multifaceted intervention and diagnosed and treated CHF patients with conventional programme (usual care). After that, a total of 256 patients with CHF were enrolled and randomly assigned to receive optimization programme [integration of usual care and traditional Chinese medicine (TCM) treatment] or conventional programme (usual care) for the treatment of CHF. The primary outcome was the change in New York Heart Association (NYHA) functional classification during 24 weeks of treatment. Results: When compared with usual care, multifaceted optimization management resulted in superior improvements in NYHA functional classification at the 12-week visit (P = 0.023), the 16-week, 20-week, and 24-week visits (P < 0.001). It also demonstrated superior performance in comparison with the conventional programme with respect to readmission rate for major adverse cardiovascular events (MACEs), readmission rate for worsening heart failure, plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, left ventricular ejection fraction (LVEF), patient TCM syndrome scores, quality of life, and patients with heart failure with reduced ejection fraction (HFrEF) in optimization group more likely received beta-blockers and ACE inhibitors or ARBs than those in control group (P = 0.038 and P = 0.013, respectively). Conclusions: It is likely that the multifaceted optimization programme used in this study is feasible would benefit patients with CHF in NYHA functional classification, readmission for worsening heart failure, plasma NT-proBNP level, LVEF, patient TCM syndrome scores, and quality of life. Additionally, it would improve hospital personnel adherence to evidence-based performance measures for HFrEF.


  • Open Access

    Effects and Safety of Non-Pharmacological Therapies of Traditional Chinese Medicine for Coronary Heart Disease: An Overview of Systematic Reviews

    by Weiqiang Ji, Lan Wu, Guangming Pan, Xu Zou

    Objectives. Coronary heart disease (CHD) is currently the leading cause of human death. Non-pharmacological therapy of traditional Chinese medicine (NPTCM) is an important characteristic therapy of traditional Chinese medicine (TCM). Questions concerning the efficacy and safety of NPTCM-related interventions in patients with CHD led us to conduct this overview of systematic reviews (SRs). Methods. The Cochrane Library, PubMed, Embase, EBSCO, Epistemonikos, PROSPERO, CNKI, Wanfang Database, and SinoMed were searched without language and publication status restriction from their inception to May 2021, along with grey literature sites and reference lists of included reviews. Systematic reviews comparing NPTCM/a combination of NPTCM and non-TCM interventions with non-TCM interventions/inactive controls for CHD were examined. Two reviewers independently screened titles, abstracts, and full-text articles, and completed data extraction and quality appraisal according to the predefined standards. Results. In total, 1494 titles and abstracts and 66 full-text articles were screened, and a total of 12 SRs (11 with meta-analysis) were finally included. According to PRISMA 2020 checklist, more than 50 of reviews conformed to 80 of 54 items. Consistent evidence of effectiveness or harms across multiple outcomes based on more than one moderate quality review with meta-analysis was found for acupuncture and usual care plus acupuncture/Baduanjin/TCM exercise therapies/TCM emotional therapy. These interventions were mostly evaluated less than 6 months. Conclusion. Acupuncture or acupuncture plus usual care could improve angina symptoms and ECG, and usual care plus Baduanjin/TCM exercise therapies could ameliorate health-related quality of life. Additionally, Baduanjin plus usual care could also improve psychological condition, and it as well as acupuncture could be safe due to no reports on adverse events related to these interventions. TCM emotional therapy plus usual care could benefit patients with CHD and depression.